
		 At 3 months of age, she experienced epileptic spasms and electroencephalography (EEG) revealed hypsarrhythmia. 
		 At 3 years 2 months, she exhibited focal impaired awareness seizures, 
		 which responded well to a combination of clonazepam (CZP) and zonisamide. At 4 years of age, myoclonic seizures 
		 appeared and occurred five times per week despite the administration of antiepileptic medications. 
		 Her psychomotor development was severely delayed. Her younger sister present simialr symptoms with 
		 epileptic spasms onset at the age of 4 months.
		